Скачать или смотреть March 2023 ACC - 2023 CROI Update

Objectives:
Describe contributions to the research field in HIV and COVID-19 by the AIDS Clinical Trials Group.
Evaluate the evidence behind investigational and newly approved antiretroviral therapy regimens for intermittent dosing and possibility of contributing toward HIV remission.
Review key studies related to antiretroviral treatment from CROI 2023.
Understand range of biomedical HIV prevention approaches.
Recognize limitations of novel agents for HIV pre-exposure prophylaxis.


Presented by:
Rachel Bender Ignacio, MD, MPH
Assistant Professor
Vaccine and Infectious Disease Division, Fred Hutch
Medical Director
COVID-19 Clinical Research Center, Fred Hutch
Assistant Professor,
Department of Medicine, Division of Allergy & Infectious Diseases,
University of Washington

Jehan Budak, MD
Assistant Professor
Department of Medicine, Division of Allergy & Infectious Diseases
Assistant Medical Director, Madison Clinic
Harborview Medical Center
HIV Pathway Director,
UW Internal Medicine Residency

Chase Cannon, MD
Co-Director,
Public Health Seattle King County Sexual Health Clinic
Acting Assistant Professor,
Department of Medicine, Division of Allergy & Infectious Diseases,
University of Washington